Literature DB >> 7636479

Equine arteritis virus-neutralizing antibody in the horse is induced by a determinant on the large envelope glycoprotein GL.

E D Chirnside1, A A de Vries, J A Mumford, P J Rottier.   

Abstract

Complementary DNAs encoding ORFs 2 to 7 equine arteritis virus (EAV) have been cloned into the expression vector pGEX to produce glutathione-S-transferase fusion proteins. Recombinant proteins were affinity purified and screened in ELISA with equine sera to identify immunoreactive polypeptides. The large envelope glycoprotein (GL) was identified as the most reactive to EAV-positive equine sera and an immuno-dominant epitope was mapped between amino acids 55 and 98 by subcloning and expression. A fusion protein covering this region and a GL-specific synthetic peptide (residues 75 through 97) induced EAV-neutralizing antibody in vaccinated horses. The defined antigenic region of GL is likely to be exposed on the surface of the native EAV virion and consequently may be useful in the development of diagnostic tests and vaccines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636479     DOI: 10.1099/0022-1317-76-8-1989

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  20 in total

1.  Monoclonal antibodies directed against conserved epitopes on the nucleocapsid protein and the major envelope glycoprotein of equine arteritis virus.

Authors:  E Weiland; S Bolz; F Weiland; W Herbst; M J Raamsman; P J Rottier; A A De Vries
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Comparison of nucleic and amino acid sequences and phylogenetic analysis of the Gs protein of various equine arteritis virus isolates.

Authors:  N Lepage; G St-Laurent; S Carman; D Archambault
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Hemagglutinin-esterase, a novel structural protein of torovirus.

Authors:  L A Cornelissen; C M Wierda; F J van der Meer; A A Herrewegh; M C Horzinek; H F Egberink; R J de Groot
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Detection of antibodies to equine arteritis virus by a monoclonal antibody-based blocking ELISA.

Authors:  H J Cho; S C Entz; D Deregt; L T Jordan; P J Timoney; W H McCollum
Journal:  Can J Vet Res       Date:  2000-01       Impact factor: 1.310

5.  Heterodimerization of the two major envelope proteins is essential for arterivirus infectivity.

Authors:  Eric J Snijder; Jessika C Dobbe; Willy J M Spaan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Biosynthesis of glycoproteins E and I of feline herpesvirus: gE-gI interaction is required for intracellular transport.

Authors:  J D Mijnes; L M van der Horst; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain.

Authors:  Javier Castillo-Olivares; Roeland Wieringa; Tamás Bakonyi; Antoine A F de Vries; Nick J Davis-Poynter; Peter J M Rottier
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Genomic and antigenic variations of porcine reproductive and respiratory syndrome virus major envelope GP5 glycoprotein.

Authors:  B Pirzadeh; C A Gagnon; S Dea
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

9.  Nucleotide sequence and genetic analysis of the leader region of Canadian, American and European equine arteritis virus isolates.

Authors:  A Kheyar; G St-Laurent; M Diouri; D Archambault
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

10.  Development of a fluorescent-microsphere immunoassay for detection of antibodies specific to equine arteritis virus and comparison with the virus neutralization test.

Authors:  Yun Young Go; Susan J Wong; Adam J Branscum; Valerie L Demarest; Kathleen M Shuck; Mary L Vickers; Jianqiang Zhang; William H McCollum; Peter J Timoney; Udeni B R Balasuriya
Journal:  Clin Vaccine Immunol       Date:  2007-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.